ClinConnect ClinConnect Logo
Search / Trial NCT05815745

"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)

Launched by IMPERIAL COLLEGE LONDON · Apr 4, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The PROTECT-HF trial is studying two different methods of pacing the heart to help people with slow heart rates, a condition known as bradycardia. This trial will compare the traditional method, called right ventricular pacing, with a newer approach known as physiological pacing, which includes techniques called His bundle pacing and left bundle branch area pacing. The study will involve around 2,600 patients who will be randomly assigned to receive one of the two pacing methods. Researchers will monitor patients’ progress over time to see which method works better for maintaining heart health.

To participate in this trial, individuals must be over 18 years old and have a heart function that is still above a certain level, with specific heart rhythm issues that require a pacemaker. For example, those with various types of heart block or slow atrial fibrillation may qualify. Participants can expect to have their pacemaker implanted at one of the study centers, and their health will be monitored regularly for two years. Importantly, both patients and the assessors will not know which pacing method a participant receives to ensure an unbiased study. This trial aims to improve our understanding of how these pacing techniques affect heart function over time.

Gender

ALL

Eligibility criteria

  • We will recruit patients who are referred for clinically indicated pacemaker implantation
  • Inclusion Criteria:
  • 1. Adults aged over 18 with left ventricular ejection fraction \>35% and one or more of the following guideline based ventricular pacing indications:
  • 1. Permanent or intermittent 3rd degree AV block
  • 2. Permanent or intermittent Mobitz type II AV block
  • 3. First Degree AV block with a pacing indication
  • 4. Slow chronic Atrial Fibrillation or Proposed AV node ablation
  • 5. Bifascicular block with a pacing indication
  • 6. Trifascicular block with a pacing indication
  • 7. Wenckebach with a pacing indication
  • Exclusion Criteria:
  • 1. Patients who are likely to only need occasional ventricular pacing, i.e. those with isolated sick sinus syndrome.
  • 2. Pregnant women.
  • 3. Unable to provide informed consent.
  • 4. Those with comorbidity leading to a life expectancy \<1year.

About Imperial College London

Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.

Locations

London, , United Kingdom

Aberdeen, , United Kingdom

Edinburgh, , United Kingdom

Nottingham, , United Kingdom

Rotherham, , United Kingdom

Torquay, , United Kingdom

London, , United Kingdom

Leicester, , United Kingdom

Birmingham, , United Kingdom

London, , United Kingdom

Bristol, , United Kingdom

Taunton, , United Kingdom

Chichester, , United Kingdom

York, , United Kingdom

Plymouth, , United Kingdom

Oxford, , United Kingdom

Liverpool, , United Kingdom

Brighton, , United Kingdom

Portsmouth, , United Kingdom

Swansea, , United Kingdom

Middlesbrough, , United Kingdom

Reading, , United Kingdom

Dublin, , Ireland

Larbert, , United Kingdom

Coventry, , United Kingdom

Slough, , United Kingdom

Gillingham, , United Kingdom

Leeds, , United Kingdom

Nottingham, , United Kingdom

High Wycombe, , United Kingdom

Birmingham, , United Kingdom

Cambridge, , United Kingdom

Fife Keith, , United Kingdom

Bournemouth, , United Kingdom

Croydon, , United Kingdom

London, , United Kingdom

London, , United Kingdom

London, , United Kingdom

Redhill, , United Kingdom

Sheffield, , United Kingdom

Southampton, , United Kingdom

Swindon, , United Kingdom

Worthing, , United Kingdom

Ljubljana, , Slovenia

Barking, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials